Skip to main content
. 2022 Jul 6;3(2):77–83. doi: 10.2478/rir-2022-0013

Figure 3.

Figure 3

WPI, SS score, VAS for pain, SF-36 score, and FIQ score changes in patients receiving the active treatment and placebo (dotted lines represents the expected changes in the active treatment group if no effect was observed). FIQ, fibromyalgia impact questionnaire; SS, symptom severity; VAS, visual analog score; WPI, widespread pain index.